Doprinos visokokvalitetnih valsartana liječenju arterijske hipertenzije i drugih bolesti već više od 15 godina

G Marinšek, A Glavač Povhe, D Milovanovič Jarh… - Cardiologia …, 2022 - hrcak.srce.hr
Valsartan is an angiotensin receptor antagonist used for the treatment of hypertension, heart
failure, and post-myocardial infarction. It has demonstrated efficacy and safety, while also …

[HTML][HTML] High-quality Valsartans Contributing to the Treatment of Hypertension and Beyond for More than 15 Years

G Marinšek, A Glavač Povhe, D Milovanovič Jarh… - Cardiologia …, 2022 - hrcak.srce.hr
Valsartan is an angiotensin receptor antagonist used for the treatment of hypertension, heart
failure, and post-myocardial infarction. It has demonstrated efficacy and safety, while also …

[PDF][PDF] Valsartan: a brief current review

A Abdullah, MF Rusli - Pharmacophore, 2020 - pharmacophorejournal.com
Hypertension is a multifactorial medical condition which essentially described as persistently
high blood pressure exceeding the normal range of blood pressure which is set at systolic …

A drug safety evaluation of valsartan

R Fogari, A Zoppi - Expert Opinion on Drug Safety, 2011 - Taylor & Francis
Introduction: Angiotensin receptor blockers (ARBs) as a class are generally considered safe
and better tolerated than other antihypertensive drugs. The purpose of this report is to review …

[PDF][PDF] Valsartan in the treatment of hypertension

S Alajbegovic, A Sukalo, A Alajbegovic, JD Vranic… - Med Arh, 2013 - academia.edu
Hypertension is the most important chronic health problem. It is estimated that hypertension
affects approximately one billion people and that this number will increase by 60% until the …

Valsartan in the treatment of hypertension

SE Kjeldsen, HR Brunner, GT McInnes, P Stolt - 2005 - Future Medicine
Valsartan is a widely used, efficacious and very well-tolerated antihypertensive agent. By
specifically blocking the action of angiotensin II on the angiotensin Type 1 receptor …

[PDF][PDF] Hypertension and valsartan

P Kizilirmak, AY Üresin - The Anatolian Journal of Cardiology, 2014 - jag.journalagent.com
Hypertension, which is pointed to be the most frequent cause of death in the World and in
Turkey and defined by the World Health Organization as global health crisis and the …

[PDF][PDF] The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial in Slovakia

T Jezek, I Balazovjech - Bratislavske lekarske listy, 2003 - bmj.fmed.uniba.sk
Objectives: We described the baseline characteristics of a cohort of patients who are a part
of a large prospective study and compared with those characteristics of patients enrolled …

The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials

NB Mistry, AS Westheim… - Expert opinion on …, 2006 - Taylor & Francis
Valsartan is an angiotensin receptor antagonist that specifically blocks the angiotensin II
type 1 receptors. It is an effective and well-tolerated once-daily antihypertensive agent, with …

[HTML][HTML] A study of prescribing valsartan in Out-patient Clinics at the Royal Hospital, Muscat, Oman

Z Al-Salmi, F Al-Raisi, A Al-Harbi… - Oman Medical …, 2009 - ncbi.nlm.nih.gov
Objectives Angiotensin Receptor Blockers such as Valsartan, are a newer class of drugs
associated with significant reductions in cardiovascular morbidity and mortality. They are …